the Effects of Different Exercise on Vascular Health
Research on the Effect of Lifestyle Intervention Combined With Wearable Devices Based on Different Exercise on Vascular Health
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Detailed Description
Study Type
Study Type
Enrollment (Estimated)
Enrollment
Phase
Phase
- Not Applicable
Contacts and Locations
Study Contact
Study Contact
- Name: Yifan Wu
- Phone Number: 01088398069
- Email: wuyifan1127@126.com
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Age: ≥ 18 years old and < 60 years old;
- cfPWV>10m/s;
- Those who have 1 intelligent communication device and can use it proficiently (Android mobile phone is preferred);
- People who have lived and/or worked relatively steadily in the past 6 months;
- Signed informed consent.
Exclusion Criteria:
- Moderate to severe obesity (≥30kg/m^2);
- Acute myocardial infarction, acute tachyarrhythmia, pulmonary edema, severe aortic stenosis and other serious circulatory respiratory diseases and acute cardiovascular and cerebrovascular diseases;
- severe essential hypertension (systolic blood pressure ≥180mmHg and/or diastolic blood pressure ≥110mmHg) or poorly controlled essential hypertension;
- Patients with secondary hypertension, acute hypertension, subacute hypertension and hypertensive encephalopathy;
- Significant arrhythmia (atrial fibrillation, etc.);
- Patients with atherosclerotic cardiovascular diseases, such as coronary heart disease, severe peripheral atherosclerotic diseases, etc.;
- Type 1 diabetes, uncontrolled type 2 diabetes or other diseases affecting carbohydrate metabolism;
- Severe stenosis of the carotid and/or femoral arteries (resulting in significant abnormalities in the blood flow spectrum); Those who have anatomical abnormalities of the aorta and major branches and cannot complete PWV detection;
- Cancer and other major comorbidities affecting arterial blood pressure;
- Those who are unable to exercise due to fractures, joint instability and other physical diseases or diseases affecting the locomotor system;
- Those who have involuntary physical movements due to mental illness, epilepsy or other diseases;
- Those who have a pacemaker installed;
- Pregnant/trying to conceive;
- Patients with allergies, limb trauma or skin diseases who cannot cooperate with the completion of ABI and baPWV index examinations;
- Those who have undergone or plan to have bariatric surgery in the next 12 months;
- Those who have participated in other clinical studies in the past 3 months;
- Refusal to sign informed consent.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Number of Arms
Arms and Interventions
Participant Group / ArmParticipant Group / Arm |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
No Intervention: Control
Study participants were given training on dietary patterns, regular monitoring and follow-up through apps and wearable devices, and no forced exercise measures were performed.
|
|
|
Active Comparator: Combined Exercise Group
Study participants were given training on dietary patterns, regular monitoring and follow-up through apps and wearable devices.Based on the status of the study participants and the results of the cardiopulmonary exercise test, the investigators prescribe moderate-intensity aerobic exercise combined with resistance exercise
|
Based on the study participant's status and exercise assessment, the investigators prescribe moderate-intensity aerobic exercise combined with resistance exercise.
Before each exercise, preparatory activities (10min), 20-30min moderate-intensity aerobic exercise, finishing activities (10min) at the end, 5 days/week, for 12 weeks, and at the same time, choose non-consecutive 3 days of resistance training in 5 aerobic training sessions to increase resistance training (choose 1~2 muscle groups each time, 4~5 movements, repeat each action 8~12 times, repeat 2~3 sets)
|
|
Experimental: Mind-body Exercise Group
Study participants were given training on dietary patterns, regular monitoring and follow-up through apps and wearable devices.A standardized Baduanjin exercise program consists of eight postures, each training time is about 30 minutes (including 10 min warm-up, 2 times of Baduanjin, and 10 min of relaxation), 5 days/week, a total of 12 weeks.
|
A professional therapist instructed the participants to learn and train Baduanjin before the intervention, and a standardized Baduanjin exercise program included eight postures, each training time was about 50 minutes (including 10 min of warm-up, 2 times of Baduanjin, and 10 min of relaxation), 5 days/week, a total of 12 weeks
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Cervical femoral pulse wave velocity(cfPWV)
Time Frame: baseline,3months,6months,9 months
|
The cardio-cerebrovascular and aortic function detector (Campura, France, model: Complior Analyse) was used to measure cfPWV, and the study participants were in a supine position, lying flat on the pillow, with their palms up on their sides of the body, so that their whole body was relaxed and rested for about 3 minutes.
PWV can reflect arterial stiffness, and the European Society of Cardiology recommends cfPWV >10 m/s as the definitive threshold for assessing arterial functional changes in hypertension.We monitored cfPWV at baseline,3,6,9 months of the study.
|
baseline,3months,6months,9 months
|
Secondary Outcome Measures
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Brachi-ankle pulse wave velocity(baPWV)
Time Frame: baseline,3months,6months,9 months
|
The blood pressure of the limbs is measured with the Omron arteriosclerosis detector, and the pulse conduction velocity (baPWV) and ankle-brachial index (ABI) are calculated to automatically evaluate the degree of arteriosclerosis and blood vessel blockage.
Positive criteria for baPWV: ≥1400 cm/s or baPWV% ≥ 19% is arteriosclerosis.
Lower extremity vascular occlusion (ABI positive criteria): ≤0.9 for peripheral arterial stenosis and ≤0.5 for possible peripheral arterial occlusion.We monitored baPWV at baseline,3,6,9 months of the study.
|
baseline,3months,6months,9 months
|
|
blood pressure
Time Frame: baseline,3months,6months,9 months
|
Blood pressure indicator: systolic blood pressure and diastolic blood pressure.We monitored blood pressure at baseline,3,6,9 months of the study.
|
baseline,3months,6months,9 months
|
|
body weight
Time Frame: baseline,3months,6months,9 months
|
Using bioelectrical impedance analysis to monitor body weight,weight and height will be combined to report BMI in kg/m^2.We monitored body composition at baseline,3,6,9 months of the study.
|
baseline,3months,6months,9 months
|
|
Lipid metabolism parameters: TC(mmol/L), TG(mmol/L), HDL-C(mmol/L), LDL-C(mmol/L)
Time Frame: baseline,3months,6months,9 months
|
Lipid metabolism indicators: total cholesterol , triglyceride , high density lipoprotein cholesterol, low density lipoprotein cholesterol.We monitored lipid metabolism parameters at baseline,3,6,9 months of the study.
|
baseline,3months,6months,9 months
|
|
Physical fitness
Time Frame: baseline,3months,6months,9 months
|
The measurement of muscle strength, balance and flexibility is completed by the rehabilitation therapist, mainly including: (1) upper limb muscle strength test (dumbbell arm curl test); (2) Lower limb muscle strength test (chair standing and sitting test); (3) balance ability test; (4) Lower limb flexibility assessment (chair sitting body forward bending test); (5) Upper limb flexibility assessment (two-hand dorsum extension test).
Participants were observed for changes at baseline, 3,6,9 months.
|
baseline,3months,6months,9 months
|
|
Vascular Health Index
Time Frame: baseline,3months,6months,9 months
|
The PWV was analyzed by the smart watch through ECG (electrocardiogram) and PPG (photoplethysmography) sensors to evaluate the degree of vascular elasticity, and the vascular health index and evaluation were obtained, and the results were divided into low-risk, medium-risk, and high-risk.
|
baseline,3months,6months,9 months
|
|
Application adherence
Time Frame: baseline,3months,6months,9 months
|
Study participants who received remote lifestyle interventions through the app, completed all exercise training content per week, or clocked in ≥ exercise 3 times were considered to have good compliance; Those who check in < exercise 3 times a week are considered to have poor compliance.
|
baseline,3months,6months,9 months
|
Collaborators and Investigators
Sponsor
Sponsor
Investigators
Investigators
- Principal Investigator: Xue Feng, Fuwai Hospital
Study record dates
Study Major Dates
Study Start (Estimated)
Study Start
Primary Completion (Estimated)
Primary Completion
Study Completion (Estimated)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Actual)
First Posted
Study Record Updates
Last Update Posted (Actual)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
Other Study ID Numbers
- 2023-ZX067
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.